
Yunnan Botanee Bio-Tech Group
Science-powered care for skin health and beauty.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
* | CNY351m Valuation: CNY14.0b 2.2x EV/Revenue 16.9x EV/EBITDA | Secondary | |
Total Funding | 000k |
CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 36 % | 53 % | 25 % | 10 % | 4 % | 10 % | 11 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 26 % | 27 % | 27 % | 19 % | 14 % | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 21 % | 21 % | 21 % | 14 % | 9 % | - | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 2 % | 3 % | 5 % | 5 % | 5 % | - | - |
Source: Company filings or news article, Equity research estimates
Yunnan Botanee Bio-Technology Group Co., Ltd. is a publicly traded entity on the Shenzhen Stock Exchange, operating within China's expansive health and wellness industry. Incorporated in 2010, the company has strategically positioned itself at the intersection of skincare and the internet, focusing on what it terms the "Skin Health Internet+" sector. The company's journey includes a significant milestone on March 25, 2021, when it was listed on the ChiNext Market of the Shenzhen Stock Exchange, marking it as a pioneer in China's functional skincare products category.
At the helm is Chairman and General Manager, Dr. Guo Zhenyu, who holds a doctorate in Electrical Engineering and has an extensive background in academia and the pharmaceutical industry. His experience includes roles at the University of New Brunswick and the School of Engineering at George Washington University, as well as leadership positions at Dihon Pharmaceutical Group. This blend of scientific and business acumen has shaped Botanee's direction.
The core of Botanee's business revolves around the research, development, production, and marketing of skincare products, with a specialized focus on sensitive skin. The company leverages the rich biodiversity of the Yunnan plateau, investigating indigenous plants to discover active ingredients for its product lines. This approach has led to the creation of its flagship brand, "Winona," which utilizes dermatological-grade formulas and adheres to Good Manufacturing Practice of Cosmetics (GMPC) standards. The product portfolio is diverse, including creams, lotions, masks, and essences, as well as makeup items like primers and removers. Beyond consumer cosmetics, Botanee is also engaged in the medical instruments sector, producing items such as hyaluronic acid repair biofilms and dressings for post-procedure skin care. The company's brand family has expanded to include Winona Baby, AOXMED, Beforteen, Za, and PURE&MILD.
Revenue generation is primarily driven by a dual-channel sales strategy that combines a strong online presence with offline distribution. This omnichannel retail system utilizes e-commerce platforms, retail stores, and distributors to reach a broad consumer base. The company has demonstrated consistent growth, with the Winona brand being a major contributor to its revenue. Botanee's commitment to research and development is substantial, with significant investments allocated to R&D to drive product formulation and quality enhancement.
Keywords: dermo-cosmetics, sensitive skincare, botanical extracts, functional skincare, dermatological health, Yunnan biodiversity, Winona, online retail, e-commerce beauty, skincare R&D, Chinese beauty market, public company, skincare manufacturing, medical-grade skincare, hyaluronic acid products, beauty technology, Asian skincare, natural ingredients, skin health solutions, cosmetic science